Related Experiment Video
Updated: Jan 7, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Association between intrinsic capacity, changes in intrinsic capacity, and cardiometabolic multimorbidity: results
Ziyue Wang1,2, Lu Wang1, Lulu Tang1
1Department of Nursing, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Insights
Intrinsic capacity (IC) decline is linked to higher cardiometabolic multimorbidity (CMM) risk. Even with improved IC, risk persists, highlighting the need for targeted interventions to manage CMM in aging populations.
Area of Science:
- Gerontology
- Cardiology
- Public Health
Background:
- Intrinsic capacity (IC) is crucial for maintaining cardiometabolic health in older adults.
- Declining IC is associated with increased risk of developing multiple chronic conditions.
- Understanding the relationship between IC and cardiometabolic multimorbidity (CMM) is vital for preventative health strategies.
Purpose of the Study:
- To investigate the association between baseline IC, cumulative IC scores, and dynamic changes in IC with the risk of incident CMM.
- To analyze how different levels of IC and its changes over time impact CMM development.
Main Methods:
- Utilized data from three large prospective cohort studies: CHARLS, ELSA, and HRS.
- Employed Kaplan-Meier curves and Cox proportional hazards models to assess risk trends and associations.
- Included 11,916 eligible participants for the analysis.
Main Results:
- Higher baseline IC reduction was associated with significantly increased CMM risk (HR=1.40).
- Cumulative IC scores demonstrated a dose-response relationship with CMM risk, with substantial reductions (>1 SD) showing the highest risk (HR=1.61).
- Dynamic changes in IC also predicted CMM risk; persistent impairment (HR=1.63) and even improvement (HR=1.28) carried higher risks than stable, intact IC.
Conclusions:
- Both the level of intrinsic capacity and its changes over time are significant predictors of cardiometabolic multimorbidity risk.
- Even individuals experiencing improvements in IC remain at a higher risk compared to those with consistently intact IC.
- Developing precise strategies to mitigate IC decline and implementing individualized interventions are essential for effective CMM prevention and management.
Background:
Intrinsic capacity (IC)is closely associated with cardiometabolic health in middle-aged and older adults. The purpose of this study was to determine the associations of baseline IC, cumulative IC scores, and their dynamic changes with the risk of incident cardiometabolic multimorbidity (CMM).
Methods:
Using data from three prospective cohorts, the China Health and Retirement Longitudinal Study (CHARLS), the English Longitudinal Study of Ageing (ELSA), and the Health and Retirement Study (HRS), participants who met the eligibility criteria were included in this study. Kaplan-Meier curves and Cox models analyzed risk trends and associations.
Results:
A total of 11,916 participants were included based on the inclusion and exclusion criteria. At baseline, the risk of CMM in the injured group was significantly higher than that in the non-injured group(Pooled: HR = 1.40, 95% CI 1.30-1.52, P < 0.001); Cumulative IC scores showed a graded association with CMM risk: individuals with moderately reduced scores (≈1 SD below intact) had higher risk (HR = 1.22, 95% CI 1.09-1.36), and those with substantially reduced scores (>1 SD below intact) had even higher risk (HR = 1.61, 95% CI 1.47-1.78). For dynamic changes, CMM risk was significantly higher in persistent impairment and decline groups; even the improvement group had higher risk than the no-decline group (Decline: HR = 1.25, 95% CI 1.10-1.42, P < 0.001; Improvement: HR = 1.28, 95% CI 1.13-1.45, P < 0.001; Persistent impairment: HR = 1.63, 95% CI 1.48-1.80, P < 0.001).
Conclusions:
IC and its changes relate to CMM risk. Even with IC improvement, risk remains higher than in those with intact IC. Precise strategies to delay IC decline and individualized interventions are needed for CMM control.
More Related Videos
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
Coronary Artery Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy